Second Line Capital’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$636K Sell
4,341
-1,548
-26% -$281K 0.12% 68
2026
Q1
$950K Buy
5,889
+1,418
+32% +$230K 0.18% 67
2025
Q4
$871K Sell
4,471
-308
-6% -$73.3K 0.18% 57
2025
Q3
$1.34M Buy
4,779
+1
+0% +$255 0.28% 53
2025
Q2
$1.04M Buy
4,778
+73
+2% +$11.8K 0.24% 53
2025
Q1
$658K Buy
4,705
+920
+24% +$150K 0.17% 60
2024
Q4
$631K Sell
3,785
-31
-0.8% -$5.51K 0.17% 55
2024
Q3
$650K Buy
3,816
+58
+2% +$8.4K 0.18% 57
2024
Q2
$531K Buy
+3,758
New +$467K 0.16% 61

Other funds holding ORCL

Second Line Capital's ORCL Position: Q2 2026 in Review

Second Line Capital reduced its Oracle (ORCL) stake by 26% in Q2 2026, selling an estimated $281K and leaving 4,341 shares worth $636K. The position accounts for 0.12% of the portfolio, ranked #68.

Second Line Capital first reported a position in ORCL in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.34M in Q3 2025. 3,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Second Line Capital held 4,341 shares of Oracle worth $636K as of Q2 2026.
  • Second Line Capital sold 1,548 Oracle shares in Q2 2026, an estimated $281K.
  • Oracle made up 0.12% of Second Line Capital's portfolio in Q2 2026, its #68 holding.
  • Second Line Capital first reported a position in Oracle in Q2 2024 and has held it in 9 quarters since.
  • Second Line Capital's Oracle position peaked at $1.34M in Q3 2025.
  • 3,537 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Second Line Capital's 13F filing for Q2 2026, filed 12 Aug 2026.